Just doing some dd, came up with these news releases for these two companies regarding  their test results.Now I dono about you all but I am going to go with the winner not the play offs. The winner of the battle of the SPIT is SONA imo. I did some research, I know should have done this before but it was a knee jerk reaction to something that I read. I think I lucked out.
Someone on this board keeps insisting that THRM is the better product because it’s 4x cheaper and that was about it oh and to insinuate it was 100 sensitive with no proof.  I have proof that SONA technically is the better of the two. I have two news releases, one for each company that will show the edge we/SONA have in this race. It is very, very much a race which will declare a winner in about 2 to 3 weeks, maybe a month at the latest any longer, SELL!
Here are two reason I think we’re going to be the winner.
1.    1st reason - News Release for SONA, 2020-08-25  “Sona Nanotech Inc.'s rapid detection COVID-19 antigen test achieved a sensitivity of 84.6 per cent and a specificity of 90 per cent in a study across 99 collected clinical patient samples, which included 39 positive samples and 60 negative samples, as determined by RT-PCR testing. The company is now continuing its submission of data to both the Food and Drug Administration and Health Canada to support their requirements for emergency use authorization approvals. “
News release for THRM “2020-12-07 14:20 PT - THERMA BRIGHT ACHIEVES HIGH ACCURACY RESULTS FROM FEASIBILITY STUDIES FOR ITS COVID-19 RAPID SALIVA TEST, COVISAFE
Preliminary results achieved during the feasibility studies have indicated a test sensitivity of 80 per cent and a specificity of over 90 per cent for Therma Bright Inc.'s CoviSafe rapid test for detecting SARS-CoV-2 in saliva.”
2.    2nd Reason Were about to start another Trial , 2021-04-22 13:56 PT - News Release “Sona Nanotech Inc. has received research ethics board approval for its clinical trial of the Sona saliva COVID-19 rapid test. The trial, which will seek to test up to 500 emergency room patients suspected of having COVID-19, is expected to commence next week. The company will update the market with results from the trial upon completion.”
This train is leaving, couple three weeks to accumulate….

Unless THRM is doing something this week or two, we will win the race no doubt about it. Allllll ABOoooorrrrd
Oops just thought of a third reason.
3.    THRM - Shares outstanding - 210,470,619, Market Cap - 93,659,000
SONA – Shares outstanding - 52,199,520,   Market Cap - 99,179,000

Who’s your daddy?